TARGETING OF MYC BY HDAC INHIBITION IN MYC AMPLIFIED GROUP 3 MEDULLOBLASTOMA

被引：0

作者：

Ecker, Jonas ^{[1
,2
,3
,4
]}

Oehme, Ina ^{[1
,2
]}

Selt, Florian ^{[1
,2
,3
,4
]}

Kool, Marcel ^{[2
,5
]}

Chavez, Lukas ^{[2
,5
]}

Hohloch, Juliane ^{[1
,2
]}

Valinciute, Gintvile ^{[1
,2
]}

van Tilburg, Cornelis M. ^{[3
,4
]}

Schnolzer, Martina ^{[6
]}

Warnken, Uwe ^{[6
]}

Wechsler-Reya, Robert ^{[7
]}

Pfister, Stefan M. ^{[2
,3
,4
,5
]}

Witt, Olaf ^{[1
,2
,3
,4
]}

Milde, Till ^{[1
,2
,3
,4
]}

机构：

[1] German Canc Res Ctr, Clin Cooperat Unit Pediat Oncol, Preclin Program, Hopp Childrens Canc Ctr,NCT KiTZ, Heidelberg, Germany

[2] German Canc Consortium DKTK, Heidelberg, Germany

[3] German Canc Res Ctr, Ctr Individualized Pediat Oncol ZIPO & Brain Tumo, Translat Program, Hopp Childrens Canc Ctr,NCT KiTZ, Heidelberg, Germany

[4] German Canc Co, Heidelberg, Germany

[5] German Canc Res Ctr, Div Pediat Neurooncol, Preclin Program, Hopp Childrens Canc Ctr,NCT KiTZ, Heidelberg, Germany

[6] German Canc Res Ctr, Funct Proteome Anal B100, Heidelberg, Germany

[7] Sanford Burnham Prebys Med Discovery Inst, Tumor Initiat & Maintenance Program, La Jolla, CA USA

来源：

NEURO-ONCOLOGY | 2017年 / 19卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MEDU-20

引用

页码：41 / 42

页数：3

共 50 条

[31] Restoration of miR-193a expression is tumor-suppressive in MYC amplified Group 3 medulloblastoma
Bharambe, Harish Shrikrishna
Joshi, Annada
Yogi, Kedar
Kazi, Sadaf
Shirsat, Neelam Vishwanath
ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2020, 8 (01)
[32] INNATE IMMUNE EVASION IN MYC-AMPLIFIED MEDULLOBLASTOMA
Vo, Jeremy
Mitra, Juni S.
Knox, Aaron
Picard, Daniel
Vibhakar, Rajeev
Hankinson, Todd
Mitra, Siddhartha S.
NEURO-ONCOLOGY, 2024, 26
[33] CLASS I HDAC INHIBITORS AND PLK1 INHIBITORS SYNERGIZE IN MYC-AMPLIFIED MEDULLOBLASTOMA
Valinciute, Gintvile
Ecker, Jonas
Selt, Florian
Hielscher, Thomas
Schmidt, Christin
Sigaud, Romain
Ridinger, Johannes
Gatzweiler, Charlotte
Picard, Daniel
Oppermann, Sina
Blattner-Johnson, Mirjam
Jones, David T. W.
Oehme, Ina
Kool, Marcel
Remke, Marc
Pfister, Stefan M.
Witt, Olaf
Milde, Till
NEURO-ONCOLOGY, 2021, 23 : 5 - 5
[34] HDAC INHIBITORS SENSITIZE MYC-AMPLIFIED MEDULLOBLASTOMA TO IMMUNOTHERAPY BY ACTIVATING THE NF-KB PATHWAYS
Marquardt, Viktoria
Theruvath, Johanna
Pauck, David
Picard, Daniel
Reifenberger, Guido
Borkhardt, Arndt
Cheshier, Samuel
Kurz, Thomas
Remke, Marc
Mitra, Siddhartha
NEURO-ONCOLOGY, 2020, 22 : 364 - 364
[35] TARGETING MYC AND OTX2-DRIVEN TRANSCRIPTIONAL DEPENDENCIES OF GROUP 3 MEDULLOBLASTOMA THROUGH CDK7 INHIBITION
Zhang, Lei
Li, Meng
Hou, Linjun
Zhang, Liye
Tang, Yujie
NEURO-ONCOLOGY, 2019, 21 : 104 - 104
[36] OVEREXPRESSION OF MYC ALONE IS SUFFICIENT TO INITIATE GROUP 3 MEDULLOBLASTOMA
Tao, Ran
Murad, Najiba
Xu, Zhenhua
Zhang, Peng
Okonechnikov, Konstantin
Kool, Marcel
Rivero-Hinojosa, Samuel
Lazarski, Christopher
Zheng, Pan
Eberhart, Charles
Rood, Brian
Packer, Roger
Pei, Yanxin
NEURO-ONCOLOGY, 2018, 20 : 206 - 206
[37] CLINICAL AND MOLECULAR HETEROGENEITY WITHIN MYC AND MYCN AMPLIFIED MEDULLOBLASTOMA
Schwalbe, Edward
Lindsey, Janet
Hill, Rebecca
Crosier, Stephen
Ryan, Sarra
Williamson, Daniel
Kool, Marcel
Milde, Till
Pfister, Stefan
Bailey, Simon
Clifford, Steven
NEURO-ONCOLOGY, 2022, 24 : 113 - 113
[38] SILAC BASED QUANTITATIVE PROTEOMICS OF MYC-AMPLIFIED MEDULLOBLASTOMA
Staal, Jerome
Lau, Ling San
Zhang, Huizhen
Hathout, Yetrib
Brown, Kristy
Rood, Brian
NEURO-ONCOLOGY, 2015, 17 : 25 - 25
[39] Targeting Y box binding protein 1 (YBX1) in MYC-amplified medulloblastoma
Carney, Stephen
Hemenway, John
Rajendran, Ashmitha
Hathaway, Matt
Nealy, Eric
Bonatto, Christian
Tailor, Dhanir
Malhotra, Sanjay
Evans, Myron
CANCER RESEARCH, 2024, 84 (06)
[40] MYC BUT NOT MYCN GENERATES AGGRESSIVE GROUP 3 MEDULLOBLASTOMA THROUGH ARE SUPPRESSION
Mainwaring, Oliver
Weishaupt, Holger
Hutter, Sonja
Rosen, Gabriela
Annusver, Karl
Kasper, Maria
Swartling, Fredrik
NEURO-ONCOLOGY, 2019, 21 : 106 - 106

← 1 2 3 4 5 →